ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

No reported Change in Working Capital figures are available to summarize.

Change in Working Capital history

Currency unavailable · from the cash flow

No Change in Working Capital data reported for this period type.

Change in Working Capital vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Change in Working Capital for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$81.23M USD+190.8%+42.8%101.9%
WVEWave Life Sciences Ltd.LTM Mar 2026$38.08M USD-58.7%—53.0%
STOKStoke Therapeutics, Inc.LTM Mar 2026$15.28M USD+91.2%-27.6%47.6%
PRQRProQR Therapeutics N.V.LTM Mar 2026€10.48M EUR-2.6%+49.7%78.0%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$8.51M USD-85.7%+46.2%18.8%
BNTCBenitec Biopharma Inc.LTM Mar 2026$5.65M USD-736.9%——
SLNSilence Therapeutics plcLTM Mar 2026$5.6M USD——607.2%
RNAAtrium Therapeutics, Inc.FY2025$200K USD——1.1%
PRMEPrime Medicine, Inc.LTM Mar 2026$187K USD-100.3%-46.8%4.6%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-58.7%+42.8%50.3%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.